| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/19/2009 | US7534573 comprising transfecting said neurons with a nucleic acid encoding a protein that is targeted to synaptic vesicles and that fluoresces when synaptic vesicles undergo exocytosis; for use in treating epilepsy and other brain disorders |
| 05/19/2009 | US7534572 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue |
| 05/19/2009 | US7534571 ligand (referred to herein as "TREM-1-Ligand") of a myeloid cell receptor called TREM-1 (referred to herein as "TREM-1-Receptor") is a specific marker for bacterial and fungal sepsis |
| 05/19/2009 | US7534570 Method for the detection of cytosine methylations in immobilized DNA samples |
| 05/19/2009 | US7534564 Methods and compositions for polypeptide engineering |
| 05/19/2009 | US7534563 Methods for producing ligand arrays |
| 05/19/2009 | US7534562 Tetrahydrofolate synthetase gene |
| 05/19/2009 | US7534561 Nucleic acid array in situ fabrication methods and arrays produced using the same |
| 05/19/2009 | US7534560 Simple catalytic DNA biosensors for ions based on color changes |
| 05/19/2009 | US7534558 In vitro diagnostic test for enterovirus infections |
| 05/19/2009 | US7534488 Graded core/shell semiconductor nanorods and nanorod barcodes |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
| 05/19/2009 | US7534426 Glutenase enzyme assays |
| 05/19/2009 | US7534425 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 05/19/2009 | US7534419 Calibration using chaperone protein |
| 05/19/2009 | US7534393 Fertility computing system and method |
| 05/19/2009 | US7534336 Continuous flow particle concentrator |
| 05/19/2009 | US7534331 Use of microfluidic systems in the electrochemical detection of target analytes |
| 05/19/2009 | US7534330 Epoxy enhanced polymer membrane to increase durability of biosensors |
| 05/19/2009 | US7534081 Apparatus and method for transferring samples from a source to a target |
| 05/19/2009 | US7533558 Disposable sensor for use in measuring an analyte in a gaseous sample |
| 05/19/2009 | CA2644200A1 Seafood physical characteristic estimation system and method |
| 05/19/2009 | CA2495529C Noonan syndrome gene |
| 05/19/2009 | CA2468291C Fueling nozzle with integral molecular leak sensor |
| 05/19/2009 | CA2428532C Lysate clearance and nucleic acid isolation using silanized silica matrices |
| 05/19/2009 | CA2402745C Improved microarray spotting instruments incorporating sensors and methods of using sensors for improving performance of microarray spotting instruments |
| 05/19/2009 | CA2400966C Rat model with the onset of prostate cancer |
| 05/19/2009 | CA2391812C Method, apparatus and support for testing poles |
| 05/19/2009 | CA2384831C Apparatus and method for detection of foreign bodies in products |
| 05/19/2009 | CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/19/2009 | CA2358920C A method of testing a cell sample |
| 05/19/2009 | CA2353546C Diagnosis of stage or aggressiveness of cancer |
| 05/19/2009 | CA2348379C Immunoassay for measuring human c-peptide and kit therefor |
| 05/19/2009 | CA2326791C Hardness indicator composition and method of water hardness analysis |
| 05/19/2009 | CA2312004C Site-specific preparation of polyethylene glycol-grf conjugates |
| 05/19/2009 | CA2181131C Chemiluminescent analytical method |
| 05/19/2009 | CA2032203C Amplification capture assay |
| 05/14/2009 | WO2009062199A1 EGFR/NEDD9/TGF-β LNTERACTOME AND METHODS OF USE THEREOF FOR THE IDENTIFICATION OF AGENTS HAVING EFFICACY IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS |
| 05/14/2009 | WO2009062170A1 Molecular affinity clamp technology and uses thereof |
| 05/14/2009 | WO2009062160A2 Rantes levels as a diagnostic and therapeutic for acute graft versus host disease |
| 05/14/2009 | WO2009062152A1 Methods for measuring the metabolism of cns derived biomolecules in vivo |
| 05/14/2009 | WO2009062110A1 System and method for quantifying analytes in immuno or enzymatic assays |
| 05/14/2009 | WO2009062027A1 Nonseparation assay methods using peroxide generating enzymes |
| 05/14/2009 | WO2009062022A1 Methods and compositions for the diagnosis of crohn's disease |
| 05/14/2009 | WO2009062001A1 Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-cd3/cd28 |
| 05/14/2009 | WO2009061935A2 Methods of identifying safe nmda receptor antagonists |
| 05/14/2009 | WO2009061918A1 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/14/2009 | WO2009061911A1 Assays and methods for evaluating multimeric complexes |
| 05/14/2009 | WO2009061905A1 Methods of measuring cell viability without using control cells |
| 05/14/2009 | WO2009061904A2 MASS SPECTROMETRY ASSAY FOR eIF4E AND eIF4E REGULON ACTIVITY |
| 05/14/2009 | WO2009061808A2 Colorimetric test for antimalarial artemesin derivatives |
| 05/14/2009 | WO2009061739A1 Neutralization of hcv |
| 05/14/2009 | WO2009061710A1 Method and apparatus for rapidly counting and identifying biological particles in a flow stream |
| 05/14/2009 | WO2009061697A1 Anticoagulant antagonist and hemophilia procoagulant |
| 05/14/2009 | WO2009061568A1 Biosensor coding system |
| 05/14/2009 | WO2009061515A1 Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 05/14/2009 | WO2009061412A1 Methods for detecting or monitoring cancer using lpe as a marker |
| 05/14/2009 | WO2009061404A1 Methods for detecting or monitoring cancer using lpc as a marker |
| 05/14/2009 | WO2009061369A2 Directed evolution using proteins comprising unnatural amino acids |
| 05/14/2009 | WO2009061345A2 Targeting cdk4 and cdk6 in cancer therapy |
| 05/14/2009 | WO2009061191A1 Cellular stress testing in the cardiovascular system |
| 05/14/2009 | WO2009061017A1 Bio lab-on-a-chip and method of fabricating and operating the same |
| 05/14/2009 | WO2009060804A1 Mutant nucleic acid associated with chronic myeloproliferative disorder, and method for evaluation of chronic myeloproliferative disorder |
| 05/14/2009 | WO2009060610A1 Method for in vitro evaluation of biodegradability of base material |
| 05/14/2009 | WO2009060440A1 Anti-measles cancer immunotherapy |
| 05/14/2009 | WO2009060360A2 Microelectronic opiacal evanescent field sensor |
| 05/14/2009 | WO2009060357A1 Biosensor cartridge |
| 05/14/2009 | WO2009060350A1 Microelectronic sensor device |
| 05/14/2009 | WO2009060331A2 Moisture indicator for heat and moisture exchange devices |
| 05/14/2009 | WO2009060229A1 Sulfatase enzymes |
| 05/14/2009 | WO2009060184A1 Mycobacterium antigens |
| 05/14/2009 | WO2009060169A1 Ice fraction sensor |
| 05/14/2009 | WO2009060129A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
| 05/14/2009 | WO2009060124A2 Use of oligonucleotides with modified bases in hybridization of nucleic acids |
| 05/14/2009 | WO2009060065A1 Method of quantifying transient interactions between proteins |
| 05/14/2009 | WO2009059972A2 Biochemical markers for cvd risk assessment |
| 05/14/2009 | WO2009059860A1 Method and device for detecting a tear and/or an elastic modulus of a material web |
| 05/14/2009 | WO2009059784A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/14/2009 | WO2009059751A1 Diagnostic method for determining an infection caused by or associated with siderophore-secreting microorganisms |
| 05/14/2009 | WO2009059605A1 Small scale solid state screening |
| 05/14/2009 | WO2009059433A1 Quantification of an absorber through a scattering medium |
| 05/14/2009 | WO2009059411A1 Porcine lung epithelial cell line and its use in production and detection of porcine reproductive and respiratory syndrome virus |
| 05/14/2009 | WO2009059409A1 Biomarkers for visceral leishmaniasis |
| 05/14/2009 | WO2009059404A1 Angiopoietin-1 and -2 biomarkers for infectious diseases that compromise endothelial integrity |
| 05/14/2009 | WO2009059393A1 Method for the detection of breast cancer by determining alcam and/or bcam levels in a patient sample |
| 05/14/2009 | WO2009043014A3 Devices for studying cancer invasion and migration |
| 05/14/2009 | WO2009041782A3 Method for correcting erroneous results of measurement in biosensors and apparatus using the same |
| 05/14/2009 | WO2009039854A3 Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| 05/14/2009 | WO2009039542A9 Methods of screening for compounds having anti- inflammatory activity and/or prevent / treat vascular leak |
| 05/14/2009 | WO2009037390A3 Use of the protein em6 as a performance marker for germination of seed lots and applications thereof |
| 05/14/2009 | WO2009035770A3 Cholera toxin subunit b conjugated quantum dots for live cell labelling |
| 05/14/2009 | WO2009035738A3 Use of antibody secreting cell elispot to assess antibody responses following antigen exposure |
| 05/14/2009 | WO2009035554A3 Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem |
| 05/14/2009 | WO2009032205A3 Carbon measurement in aqueous samples using oxidation at elevated temperatures and pressures |
| 05/14/2009 | WO2009031049A3 Reagents and methods for the determination of pk/adme-tox characteristics of new chemical entities and of drug candidates |
| 05/14/2009 | WO2009029971A8 Method for diagnosing the metabolic syndrome (ms) |
| 05/14/2009 | WO2009025793A3 Human t2r bitterness receptors and uses thereof |
| 05/14/2009 | WO2009017878A3 High specificity and high sensitivity detection based on steric hindrance & enzyme-related signal amplification |